UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

Nature reviews. Clinical oncology, 2010-09, Vol.7 (9), p.493-507

2010

Link zum Volltext

Verfügbarkeit prüfen

The Role of Src in Solid Tumors

The oncologist (Dayton, Ohio), 2009-07, Vol.14 (7), p.667-678

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

Cancer biology & therapy, 2011-05, Vol.11 (9), p.777-792

2011

Link zum Volltext

Verfügbarkeit prüfen

AXL mediates resistance to cetuximab therapy

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.5152-5164

2014

Link zum Volltext

Verfügbarkeit prüfen

Nuclear EGFR as a molecular target in cancer

Radiotherapy and oncology, 2013-09, Vol.108 (3), p.370-377

2013

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of resistance to HER family targeting antibodies

Experimental cell research, 2010-04, Vol.316 (7), p.1083-1100

2010

Link zum Volltext

Verfügbarkeit prüfen

p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation

Cancer research (Chicago, Ill.), 2011-11, Vol.71 (22), p.7071-7079

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

PloS one, 2010-09, Vol.5 (9), p.e12702

2010

Link zum Volltext

Verfügbarkeit prüfen

Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition

Neoplasia (New York, N.Y.), 2012-05, Vol.14 (5), p.420-IN13

2012

Link zum Volltext

Verfügbarkeit prüfen

AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer

BMC cancer, 2022-04, Vol.22 (1), p.447-447, Article 447

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

Cancers, 2024-01, Vol.16 (2), p.312

2024

Link zum Volltext

Verfügbarkeit prüfen

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck

BMC cancer, 2012-10, Vol.12 (1), p.463-463, Article 463

2012

Link zum Volltext

Verfügbarkeit prüfen

Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer

Molecular cancer therapeutics, 2014-05, Vol.13 (5), p.1356-1368

2014

Link zum Volltext

Verfügbarkeit prüfen

Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab

Neoplasia (New York, N.Y.), 2013-10, Vol.15 (10), p.1196-1206

2013

Link zum Volltext

Verfügbarkeit prüfen

Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-07, Vol.81 (1), p.138-141

2013

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Cancer biology & therapy, 2009-04, Vol.8 (8), p.696-703

2009

Link zum Volltext

Verfügbarkeit prüfen

Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers

Cancers, 2020-10, Vol.12 (10), p.2795

2020

Link zum Volltext

Verfügbarkeit prüfen

Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3

PloS one, 2013-08, Vol.8 (8), p.e71518-e71518

2013

Link zum Volltext

Verfügbarkeit prüfen

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

Clinical cancer research, 2009-03, Vol.15 (5), p.1585-1592

2009

Link zum Volltext

Verfügbarkeit prüfen

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma

Cell death & disease, 2018-01, Vol.9 (1), p.5-5, Article 5

2018

Link zum Volltext

Verfügbarkeit prüfen

An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy

Nano letters, 2020-07, Vol.20 (7), p.4901-4909

2020

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients

Oncotarget, 2018-04, Vol.9 (28), p.19793-19806

2018

Link zum Volltext

Verfügbarkeit prüfen

Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas

iScience, 2020-11, Vol.23 (11), p.101692-101692, Article 101692

2020

Link zum Volltext

Verfügbarkeit prüfen

The nuclear epidermal growth factor receptor signaling network and its role in cancer

Discovery medicine, 2011-11, Vol.12 (66), p.419-432

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond

Seminars in radiation oncology, 2009, Vol.19 (1), p.63-68

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(122)
Buchkapitel
(40)
Bücher
(4)

Sprache

Englisch
(165)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(70)
Oncology
(70)
Humans
(54)
Proteins
(53)
Animals
(45)
Cellular Biology
(42)
Mice
(36)
Cell Line, Tumor
(31)
Pharmaceutical Technology
(27)
Cancer
(26)
Cetuximab
(21)
Tumors
(20)
Antineoplastic Agents - Pharmacology
(18)
Antibodies, Monoclonal - Pharmacology
(16)
Biological And Medical Sciences
(16)
Drug Resistance, Neoplasm
(16)
Egfr
(16)
Kinases
(16)
Signal Transduction
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Understanding resistance to EGFR inhibitors-impact on future treatment strategies

The Role of Src in Solid Tumors

Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

AXL mediates resistance to cetuximab therapy

Nuclear EGFR as a molecular target in cancer

Mechanisms of resistance to HER family targeting antibodies

p53 Modulates Acquired Resistance to EGFR Inhibitors and Radiation

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition

AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer

Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck

Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer

Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab

Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer

Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab

Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers

Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma

An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients

Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas

The nuclear epidermal growth factor receptor signaling network and its role in cancer

Molecular Target Approaches in Head and Neck Cancer: Epidermal Growth Factor Receptor and Beyond

Suchergebnisse filtern